Actuate Therapeutics (ACTU) announced that the Company will be added to the Russell 3000 Index, with automatic inclusion in the Russell 2000( Index, effective after the U.S. market close on June 27, as part of the 2025 Russell indexes annual reconstitution. The inclusion follows the initial announcement on Friday, May 23, and the latest update on Friday, June 13, 2025, in connection with the annual reconstitution of the Russell U.S. Indexes.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACTU:
- Actuate Therapeutics Hosts Key Opinion Leader Event
- Actuate Therapeutics shares highlights from KOL eventon elraglusib data
- Actuate Therapeutics Reports Positive Phase 2 Trial Results
- Promising Clinical Trial Results Justify Buy Rating for Actuate Therapeutics’ Elraglusib
- Actuate Therapeutics Elects Directors at Annual Meeting